Opaleye Management Inc. (Trades, Portfolio), a prominent investment firm, has recently expanded its portfolio by adding a significant number of shares in Harrow Inc. (NASDAQ:HROW). On November 15, 2023, the firm acquired 25,000 additional shares of Harrow Inc., a key player in the eyecare pharmaceutical industry. Following this addition, Opaleye Management Inc. (Trades, Portfolio) now holds a total of 3,645,000 shares in Harrow Inc., representing a substantial 10.38% of the company's outstanding shares and a 7% position in the firm's investment portfolio.
Westside Investment Management Inc. reduced its stake in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 11.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 133,744 shares of the company’s stock after selling 16,865 shares during the quarter. Westside Investment […]
StockNews.com initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a report released on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities analysts also recently commented on TCON. Jonestrading restated a hold rating on shares of TRACON Pharmaceuticals in a research note […]
HC Wainwright Cuts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $33 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.